全文获取类型
收费全文 | 7917篇 |
免费 | 616篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 343篇 |
妇产科学 | 234篇 |
基础医学 | 1145篇 |
口腔科学 | 83篇 |
临床医学 | 1120篇 |
内科学 | 1411篇 |
皮肤病学 | 187篇 |
神经病学 | 885篇 |
特种医学 | 152篇 |
外科学 | 721篇 |
综合类 | 72篇 |
一般理论 | 12篇 |
预防医学 | 983篇 |
眼科学 | 95篇 |
药学 | 453篇 |
中国医学 | 3篇 |
肿瘤学 | 625篇 |
出版年
2023年 | 46篇 |
2022年 | 53篇 |
2021年 | 175篇 |
2020年 | 115篇 |
2019年 | 182篇 |
2018年 | 196篇 |
2017年 | 154篇 |
2016年 | 159篇 |
2015年 | 174篇 |
2014年 | 267篇 |
2013年 | 498篇 |
2012年 | 578篇 |
2011年 | 587篇 |
2010年 | 341篇 |
2009年 | 310篇 |
2008年 | 496篇 |
2007年 | 589篇 |
2006年 | 507篇 |
2005年 | 461篇 |
2004年 | 438篇 |
2003年 | 416篇 |
2002年 | 383篇 |
2001年 | 60篇 |
2000年 | 41篇 |
1999年 | 74篇 |
1998年 | 94篇 |
1997年 | 87篇 |
1996年 | 68篇 |
1995年 | 69篇 |
1994年 | 60篇 |
1993年 | 40篇 |
1992年 | 49篇 |
1991年 | 33篇 |
1990年 | 36篇 |
1989年 | 50篇 |
1988年 | 47篇 |
1987年 | 47篇 |
1986年 | 44篇 |
1985年 | 46篇 |
1984年 | 46篇 |
1983年 | 40篇 |
1982年 | 43篇 |
1981年 | 39篇 |
1980年 | 34篇 |
1978年 | 16篇 |
1977年 | 19篇 |
1976年 | 18篇 |
1975年 | 16篇 |
1974年 | 21篇 |
1973年 | 22篇 |
排序方式: 共有8569条查询结果,搜索用时 31 毫秒
991.
Frances Cirino Wilmore C Webley Corrie West Nancy L Croteau Chester Andrzejewski Elizabeth S Stuart 《BMC infectious diseases》2006,6(1):23
Background
Chlamydia trachomatis (Ct) and Chlamydia pneumoniae (Cp) are medically significant infectious agents associated with various chronic human pathologies. Nevertheless, specific roles in disease progression or initiation are incompletely defined. Both pathogens infect established cell lines in vitro and polymerase chain reaction (PCR) has detected Chlamydia DNA in various clinical specimens as well as in normal donor peripheral blood monocytes (PBMC). However, Chlamydia infection of other blood cell types, quantification of Chlamydia infected cells in peripheral blood and transmission of this infection in vitro have not been examined. 相似文献992.
The discovery of safe and effective therapies for perinatal hypoxia–ischemia (HI) and stroke remains an unmet goal of perinatal medicine. Hypothermia and antioxidants such as allopurinol are currently under investigation as treatments for neonatal HI. Drugs targeting apoptotic mechanisms are currently being studied in adult diseases such as cancer, stroke, and trauma and have been proposed as potential therapies for perinatal HI and stroke. Before developing antiapoptosis therapies for perinatal brain injury, we must determine whether this form of cell death plays an important role in these injuries and if the inhibition of these pathways promotes more benefit than harm. This review summarizes current evidence for apoptotic mechanisms in perinatal brain injury and addresses issues pertinent to the development of antiapoptosis therapies for perinatal HI and stroke. 相似文献
993.
Shorland W. Hosking Hugh Jones Claire E. H. Du Boulay Frances P. McGinn 《Head & neck》1993,15(1):24-28
Recent histopathologic evidence challenges the teaching that enlargement of a solitary parathyroid gland is invariably caused by an adenoma, whereas multiple gland enlargement results from hyperplasia. We have re-examined the parathyroid tissue obtained from 152 consecutive patients undergoing surgery for primary hyperparathyroidism and compared it with their clinical outcome. Our approach was to excise enlarged glands and biopsy the remainder. In 124 patients (82%) at least three glands were biopsied or removed. The ratio of adenoma to hyperplasia was reversed by our histologic re-examination; adenomas were found in only 27 patients (25 single, two double), whereas hyperplasia was found in 117 patients (one gland, 87 patients; two glands, 16 patients; three glands, five patients; four glands, nine patients). Normal tissue only was reported in eight patients. During a 2-year follow-up, five patients (3%) developed hypocalcemia and none developed recurrent hypercalcemia. Our results indicate that a full neck exploration with removal of all enlarged glands is more important than the histologic diagnosis in planning a successful surgical strategy for primary hyperparathyroidism. 相似文献
994.
995.
Arundhati S. Kale Frances Liu Raymond L. Hintz Bonita K. Baker Eileen D. Brewer Phillip D. K. Lee Susan K. Durham David R. Powell 《Pediatric nephrology (Berlin, Germany)》1996,10(4):467-473
.Serum insulin-like growth factors (IGFs), which circulate bound to specific IGF binding proteins (IGFBPs), must exit the
intravascular space before acting on target tissues. Little is known about the nature of IGF/IGFBPs in extravascular fluids
of patients with chronic renal failure (CRF). Peritoneal dialysate (PD) was studied since, after a short incubation, PD contains
proteins which have entered an extravascular space; thus, IGF/IGFBP forms in PD are more likely than serum forms to interact
with target tissues. IGF-I and IGF-II, and IGFBPs 1 – 4, were readily identified by specific immunoassays and/or 125iodine-IGF ligand blotting of simultaneously obtained PD and serum samples from seven CRF children; IGFBP-3 was a major IGFBP
in PD as in serum. Where quantitated, IGF and IGFBP levels in PD were approximately 10% of serum concentrations. After separation
of PD and serum by size-exclusion chromatography, serum had more IGFBP-3 in 150-kilodalton (kDa) than 35-kDa fractions, while
PD had far less IGFBP-3 in 150-kDa than 35-kDa fractions. Immunoblot studies revealed a major 29-kDa IGFBP-3 fragment, in
addition to intact 41- and 38-kDa IGFBP-3 forms, in PD and CRF serum; the 29-kDa form predominated in the 35-kDa PD fractions.
These data suggest that the 29-kDa fragment is the IGFBP-3 form most likely to modulate IGF effects on target tissues of CRF
individuals.
Received: April 17, 1995; received in revised form September 19, 1995; accepted October 12, 1995 相似文献
996.
997.
998.
999.
Lawrence W. Green Dr. P.H. Frances Marcus Lewis Ph.D. David M. Levine M.D. Sc.D. 《Journal of community health》1980,6(2):79-91
Survey content is necessarily limited by the investigators' foresight and by prior research on their subject of inquiry. Clinical data must supplement statistical data whenever the prior research is insufficient to delineate exactly what problems to expect. The differing perspectives on needs of patients sometimes set up competing demands. This calls for strategies based on a programmatic or population perspective that identifies the commonalities in patient educational needs from the statistical profiles, while at the same time allowing for the development of interventions that provide for as much tailoring of the educational experience based on clinical judgments as possible. By combining the community health education perspective with a clinical perspective, we were able to design interventions that responded to the educational needs of a population of low-income, black hypertensive patients. A needs assessment process that combined these perspectives began with a historical and community assessment of the problem in its most general terms. A second phase focused on the most important behavioral and organizational points for intervention. A third phase required formal assessment of predisposing, enabling, and reinforcing factors that may be determining the priority behaviors of health care organizational problems. Finally, clinical and administrative judgment sharpened and supplemented the educational interventions that were suggested by statistical data from formal surveys. Behavioral science theory was applied usefully in all these phases.At the time this study was conducted, the authors were all with the Health Services Research and Development Center and Division of Health Education, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205. Dr. Green is now Director of the Office of Health Promotion, DHEW. Dr. Lewis is currently with the Department of Community Health Care Systems, School of Nursing, University of Washington, Seattle. Correspondence and reprint requests should be addressed to Lawrence W. Green, Office of Health Promotion, Office of the Assistant Secretary for Health, U.S. Department of Health, Education, and Welfare, Room 721B, Hubert Humphrey Building, 300 Independence Avenue, S.W., Washington, D.C. 20201.Parts of this paper were presented at the Second Annual Needs Assessment Conference, March 28–31, 1978, in Louisville, Kentucky; the National Conference on High Blood Pressure Control, Los Angeles, April 3, 1978; and Endocrinology Rounds at the Indiana University Diabetes Research and Training Institute, Indianapolis, January 29, 1979. This research was supported by Grant Nos. 1R25 HL 17016-03 and IT32-H10710 from the National Heart, Lung, and Blood Institute. The authors would like to acknowledge the support and consultation of Drs. Carol Johns and R. Patterson Russell of the Johns Hopkins Hospital and of Robert Bertera, Michael Bowler, A. Judith Chwalow, Sigrid Deeds, Marion Field Fass, Brian Flynn, Michael Gross, Donald Morisky, Patricia Mullen, and Sam Shapiro of the Health Services Research and Development Center and the School of Hygiene and Public Health, Johns Hopkins University. 相似文献
1000.